Literature DB >> 20036304

beta-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO).

T Herraiz1, D González, C Ancín-Azpilicueta, V J Arán, H Guillén.   

Abstract

Peganum harmala L. is a multipurpose medicinal plant increasingly used for psychoactive recreational purposes (Ayahuasca analog). Harmaline, harmine, harmalol, harmol and tetrahydroharmine were identified and quantified as the main beta-carboline alkaloids in P. harmala extracts. Seeds and roots contained the highest levels of alkaloids with low levels in stems and leaves, and absence in flowers. Harmine and harmaline accumulated in dry seeds at 4.3% and 5.6% (w/w), respectively, harmalol at 0.6%, and tetrahydroharmine at 0.1% (w/w). Roots contained harmine and harmol with 2.0% and 1.4% (w/w), respectively. Seed extracts were potent reversible and competitive inhibitors of human monoamine oxidase (MAO-A) with an IC(50) of 27 microg/l whereas root extracts strongly inhibited MAO-A with an IC(50) of 159 microg/l. In contrast, they were poor inhibitors of MAO-B. Inhibition of MAO-A by seed extracts was quantitatively attributed to harmaline and harmine whereas inhibition by root extracts came from harmine with no additional interferences. Stems and leaves extracts were poor inhibitors of MAO. The potent inhibition of MAO-A by seed and root extracts of P. harmala containing beta-carbolines should contribute to the psychopharmacological and toxicological effects of this plant and could be the basis for its purported antidepressant actions. Copyright (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036304     DOI: 10.1016/j.fct.2009.12.019

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  63 in total

1.  Transcriptional and posttranslational inhibition of dioxin-mediated induction of CYP1A1 by harmine and harmol.

Authors:  Mohamed A M El Gendy; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Toxicol Lett       Date:  2011-10-06       Impact factor: 4.372

Review 2.  Banisteriopsis caapi, a Forgotten Potential Therapy for Parkinson's Disease?

Authors:  Atbin Djamshidian; Sabine Bernschneider-Reif; Werner Poewe; Andrew J Lees
Journal:  Mov Disord Clin Pract       Date:  2015-10-06

3.  Harmine treatment enhances short-term memory in old rats: Dissociation of cognition and the ability to perform the procedural requirements of maze testing.

Authors:  Sarah E Mennenga; Julia E Gerson; Travis Dunckley; Heather A Bimonte-Nelson
Journal:  Physiol Behav       Date:  2014-09-22

4.  Potent inhibition of human organic cation transporter 2 (hOCT2) by β-carboline alkaloids.

Authors:  David J Wagner; Haichuan Duan; Alenka Chapron; Richard W Lee; Joanne Wang
Journal:  Xenobiotica       Date:  2017-03-02       Impact factor: 1.908

5.  Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms.

Authors:  Mohamed A M El Gendy; Anatoly A Soshilov; Michael S Denison; Ayman O S El-Kadi
Journal:  Food Chem Toxicol       Date:  2011-10-21       Impact factor: 6.023

Review 6.  Dietary inhibitors of monoamine oxidase A.

Authors:  Sarah E Dixon Clarke; Rona R Ramsay
Journal:  J Neural Transm (Vienna)       Date:  2010-12-29       Impact factor: 3.575

7.  Evaluation of the effect of Peganum harmala extracts on the in vitro viability of Leishmania tropica promastigotes in comparison to Glucantime.

Authors:  Manar Madah; Shaden Haddad; Mays Khazem
Journal:  J Parasit Dis       Date:  2020-09-27

8.  Anti-tumor angiogenesis effect of a new compound: B-9-3 through interference with VEGFR2 signaling.

Authors:  Qin Ma; Wei Chen; Wen Chen
Journal:  Tumour Biol       Date:  2015-11-26

9.  Gene expression signature-based screening identifies new broadly effective influenza a antivirals.

Authors:  Laurence Josset; Julien Textoris; Béatrice Loriod; Olivier Ferraris; Vincent Moules; Bruno Lina; Catherine N'guyen; Jean-Jacques Diaz; Manuel Rosa-Calatrava
Journal:  PLoS One       Date:  2010-10-04       Impact factor: 3.240

10.  Identification of Plant-derived Alkaloids with Therapeutic Potential for Myotonic Dystrophy Type I.

Authors:  Ruben Herrendorff; Maria Teresa Faleschini; Adeline Stiefvater; Beat Erne; Tatiana Wiktorowicz; Frances Kern; Matthias Hamburger; Olivier Potterat; Jochen Kinter; Michael Sinnreich
Journal:  J Biol Chem       Date:  2016-06-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.